Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,075,390
+$502,147 QoQ
Shares Held
23,933
+11.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,324
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ausdal Financial Partners, Inc. holds $34,343,984 across 14 Drug Manufacturers - General names. MRK ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,231 | $9,872,508 | |
| 2 | ABBV |
AbbVie Inc.
|
39,096 | $9,838,116 | |
| 3 | JNJ |
Johnson & Johnson
|
18,662 | $4,739,587 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
23,933 | $3,075,390 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,985 | $2,019,544 | |
| 6 | AMGN |
Amgen Inc
|
2,893 | $1,047,612 | |
| 7 | PFE |
Pfizer Inc
|
41,679 | $1,003,629 | |
| 8 | NVS |
Novartis AG
|
4,509 | $706,649 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,075,390 | 23,933 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $2,573,243 | 21,392 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $1,763,419 | 16,753 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,580,233 | 18,828 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $720,118 | 9,097 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $597,622 | 6,658 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $726,005 | 7,298 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $992,287 | 8,738 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $1,112,590 | 8,987 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,116,428 | 8,461 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $975,292 | 8,946 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $923,564 | 8,971 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,096,666 | 9,504 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $898,889 | 8,449 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $863,301 | 7,781 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $479,430 | 5,567 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $475,360 | 5,214 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $393,347 | 4,794 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $614,346 | 8,016 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $543,045 | 7,230 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $565,621 | 7,273 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $589,584 | 7,648 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $641,229 | 7,839 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $504,833 | 6,086 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $450,602 | 5,827 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $450,945 | 5,861 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||